PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1606575
PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1606575
Clinical Chemistry and Immunoassay Industry, Global, 2023-2028
Integrated and Scalable Core Lab Solutions Driving Transformational Growth
This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to support the diagnosis and treatment of human health.
While clinical chemistry instruments and tests target different chemicals in body fluids to evaluate health and the clinical management of patients, immunoassay instruments and tests measure the presence or concentration of analytes in biological liquid by using the binding of antibodies to antigens to identify and measure certain substances. This competitive analysis examines IVD companies that provide a broad menu of clinical chemistry and immunoassay systems, including instruments and consumables. Key end-user verticals comprise hospitals, clinics, diagnostic laboratories, and research institutions. The sector is segmented by applications, including cancer/oncology, cardiac, diabetes, infectious, and others, for market revenue estimations and forecasts. The study also identifies four growth opportunities that build on trends, maximize the economic potential, and sustain value.
Table of Contents
Scope and Segmentation
- Scope of Analysis
- Segmentation
Growth Environment: Transformation in the Clinical Chemistry and Immunoassay Sector
- Why Is It Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on the Clinical Chemistry and Immunoassay Industry
Clinical Chemistry and Immunoassay Sector Ecosystem
- Competitive Environment
- Key Competitors
Growth Generator: Clinical Chemistry and Immunoassay Sector
- Growth Metrics
- Growth Drivers
- Growth Restraints
- Forecast Considerations
- Revenue Forecast
- Revenue Forecast by Application Areas
- Revenue Forecast by Region
- Revenue Forecast Analysis
- Pricing Trends and Forecast Analysis
- Revenue Share
- Revenue Share Analysis
Growth Generator: Cancer
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Region
- Forecast Analysis
Growth Generator: Cardiac
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Region
- Forecast Analysis
Growth Generator: Diabetes
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Region
- Forecast Analysis
Growth Generator: Infectious Diseases
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Region
- Forecast Analysis
Growth Generator: Others
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Region
- Forecast Analysis
Growth Opportunity Universe
- Growth Opportunity 1: Sepsis IVDs
- Growth Opportunity 2: Neurology IVDs
- Growth Opportunity 3: Routine Testing
- Growth Opportunity 4: Integrated Analyzers
Appendix & Next Steps
- Benefits and Impacts of Growth Opportunities
- Next Steps
- List of Exhibits
- Legal Disclaimer
